Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

Adam Ortopædi ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.2% 2.2%   Bankruptcy risk   2.8% 2.3% 3.8% 2.8% 2.1% 2.8% 14.4% 14.1%   Credit score (0-100)   61 66 51 58 66 58 15 15   Credit rating   BBB BBB BBB BBB BBB BBB BB BB   Credit limit (kDKK)   0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   875 885 1,036 1,180 1,362 1,229 0.0 0.0   EBITDA   256 249 3.0 200 408 45.7 0.0 0.0   EBIT   239 229 -17.1 180 391 10.9 0.0 0.0   Pre-tax profit (PTP)   236.6 227.5 -19.2 174.2 385.6 8.0 0.0 0.0   Net earnings   183.9 177.0 -15.4 135.4 300.1 6.5 0.0 0.0   Pre-tax profit without non-rec. items   237 228 -19.2 174 386 8.0 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   75.4 55.3 35.2 15.1 34.8 0.0 0.0 0.0   Shareholders equity total   462 639 513 535 721 609 344 344   Interest-bearing liabilities   136 62.8 214 348 371 480 0.0 0.0   Balance sheet total (assets)   855 1,048 1,332 1,143 1,346 1,515 344 344   Net Debt   -125 -548 -290 -72.7 -218 -215 -344 -344     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   875 885 1,036 1,180 1,362 1,229 0.0 0.0   Gross profit growth   -9.0% 1.1% 17.1% 13.9% 15.4% -9.7% -100.0% 0.0%   Employees   2 2 3 3 0 1 0 0   Employee growth %   0.0% 0.0% 50.0% 0.0% -100.0% 0.0% -100.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   855 1,048 1,332 1,143 1,346 1,515 344 344   Balance sheet change%   -15.1% 22.6% 27.1% -14.2% 17.7% 12.6% -77.3% 0.0%   Added value   256.2 249.2 3.0 200.1 411.6 45.7 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   46 -40 -40 -40 3 -70 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   2.0 3.0 -1.0 1.0 2.0 3.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   27.3% 25.9% -1.7% 15.3% 28.7% 0.9% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   25.7% 24.1% -1.4% 14.5% 31.5% 0.8% 0.0% 0.0%   ROI %   41.8% 35.3% -2.4% 22.4% 39.7% 1.1% 0.0% 0.0%   ROE %   43.5% 32.2% -2.7% 25.9% 47.8% 1.0% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   54.0% 60.9% 38.5% 46.8% 53.6% 40.2% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -48.7% -219.8% -9,699.8% -36.3% -53.5% -471.2% 0.0% 0.0%   Gearing %   29.5% 9.8% 41.8% 65.0% 51.4% 78.7% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   1.5% 1.6% 1.5% 2.1% 1.6% 1.0% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   1.6 1.8 1.3 1.4 1.7 1.6 0.0 0.0   Current Ratio   1.9 2.4 1.5 1.8 2.0 1.6 0.0 0.0   Cash and cash equivalent   261.2 610.5 504.4 420.6 588.9 694.9 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   372.8 569.8 435.1 477.7 643.7 567.2 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   128 125 1 67 0 46 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   128 125 1 67 0 46 0 0   EBIT / employee   119 115 -6 60 0 11 0 0   Net earnings / employee   92 88 -5 45 0 6 0 0